Bulletin from the Extraordinary General Meeting of Lipidor AB (publ)
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
The following resolutions were passed at the Extraordinary General Meeting (the “EGM”) of Lipidor AB (publ) (the “Company”) on 21 May 2024 in Stockholm.
Rights issue of units
The EGM resolved to approve the Board of Directors’ resolution on a new issue of units, consisting of shares and warrants of series TO 2, with pre-emption rights for the shareholders, as announced by the Company in press release on 10 April 2024 (the “Rights Issue”).
For detailed information on the terms for the Rights Issue and the resolution adopted at this EGM please see the notice that is available on the Company’s website, www.lipidor.se.
Complete terms and conditions for the Rights Issue and other information about the Company will be set out in the EU Growth prospectus prepared in connection with the Rights Issue, which is expected to be published on or around 24 May 2024.
Amendments of the Articles of Association
The EGM resolved, in accordance with the Board’s proposal, to adopt new Articles of Association. The new Articles of Association contain amended limits for the share capital and the number of shares to enable the Rights Issue. Furthermore, the new Articles of Association contain a provision allowing the General Meeting to be held digitally.